![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 401/14 | (2006.01) |
C07D 405/14 | (2013.01) | ||
C07D 401/14 | (2013.01) | ||
C07D 405/14 | (2006.01) | ||
C07D 401/12 | (2013.01) | ||
C07D 401/12 | (2006.01) | ||
A61K 31/513 | (2006.01) | ||
A61K 31/444 | (2013.01) | ||
A61K 31/506 | (2013.01) | ||
A61K 31/501 | (2006.01) | ||
A61K 31/497 | (2006.01) | ||
A61K 31/501 | (2013.01) | ||
A61P 25/00 | (2006.01) | ||
A61K 31/513 | (2013.01) | ||
A61K 31/444 | (2006.01) | ||
A61P 13/12 | (2018.01) | ||
A61K 31/506 | (2006.01) | ||
A61P 25/00 | (2018.01) | ||
A61P 25/04 | (2018.01) | ||
A61P 25/06 | (2018.01) | ||
A61P 25/14 | (2018.01) | ||
A61P 25/16 | (2018.01) | ||
A61P 25/18 | (2018.01) | ||
A61P 25/22 | (2018.01) | ||
A61P 25/24 | (2018.01) | ||
A61P 25/28 | (2018.01) | ||
A61P 25/30 | (2018.01) | ||
A61P 27/02 | (2018.01) | ||
A61P 3/04 | (2018.01) | ||
A61P 3/12 | (2018.01) | ||
A61P 31/04 | (2018.01) | ||
A61P 3/06 | (2018.01) | ||
A61P 37/02 | (2018.01) | ||
A61P 7/00 | (2018.01) | ||
A61P 7/12 | (2018.01) | ||
A61P 9/04 | (2018.01) | ||
A61P 9/10 | (2018.01) | ||
A61P 9/12 | (2018.01) | ||
A61P 3/10 | (2018.01) |
(11) | Number of the document | 3421462 |
(13) | Kind of document | T |
(96) | European patent application number | 18180416.2 |
Date of filing the European patent application | 2014-06-13 | |
(97) | Date of publication of the European application | 2019-01-02 |
(45) | Date of publication and mention of the grant of the patent | 2023-04-05 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
201361840144 P | 2013-06-27 | US |
(72) |
BRODNEY, Michael Aaron , US
DAVOREN, Jennifer Elizabeth , US
DOUNAY, Amy Beth , US
EFREMOV, Ivan Viktorovich , US
GRAY, David Lawrence Firman , US
GREEN, Michael Eric , US
HENDERSON, Jaclyn Louise , US
LEE, Chewah , US
MENTE, Scot Richard , US
O'NEIL, Steven Victor , US
ROGERS, Bruce Nelsen , US
ZHANG, Lei , US
|
(73) |
Pfizer Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
(54) | HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS |
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS |